rad onc webinar banner

Radiation Oncology Webinar Series

The Radiation Oncology Webinar Series is brought to you by the 黑料网 and the 黑料网 Commission on Radiation Oncology Education Committee.

Attend our webinars to stay informed about emerging technologies, treatment techniques and outcomes in the field of radiation oncology.

Past webinars may be viewed below or on our Radiation Oncology Webinar Series .

Upcoming Webinars

Webinar Title:

Intracranial Stereotactic Radiosurgery: Radiographic Changes after SRS and Management of Post-Treatment Toxicity

Description:

This webinar will cover radiographic changes seen on post-treatment imaging in patients with intracranial malignancies who have received stereotactic radiosurgery. National experts in radiology will review findings seen on post-treatment imaging, providing attendees the knowledge to understand how to differentiate between progression, pseudoprogression, necrosis, and benign radiographic changes. National experts in radiation oncology will then discuss options for management in patients who experience post-treatment toxicity after stereotactic radiosurgery.

Date:

May 29, 2024; 5pm EST

Webinar Format (interview, presentation etc.): 

Panel presentation

Moderator:

Emile Gogineni, DO

Confirmed Speakers:

Jana Ivanidze, MD, PhD
Samuel Chao, MD

2024 Radiation Oncology Webinar Schedule

  • Aug. 21, 2024, 5-6pm ET. Topic and registration TBA
  • Nov. 20, 2024, 5-6pm ET. Topic and registration TBA

CME Information

Title of Activity: Radiation Oncology Webinar Series, "Intracranial Stereotactic Radiosurgery: Radiographic Changes after SRS and Management of Post-Treatment Toxicity"

Date of Activity: May 29, 2024

Educational/Learning Objectives

After completing this activity, the participant should be better able to:

  1. Explain the history and current state of emerging radiation oncology treatment technologies.
  2. Identify research opportunities and clinical trials currently available related to emerging radiation oncology treatment technologies.
  3. Review active utilization of emerging radiation oncology treatment technologies domestically and abroad.
  4. Discuss future directions of emerging radiation oncology treatment technologies and the potential implications.

This webinar will cover radiographic changes seen on post-treatment imaging in patients with intracranial malignancies who have received stereotactic radiosurgery. National experts in radiology will review findings seen on post-treatment imaging, providing attendees the knowledge to understand how to differentiate between progression, pseudoprogression, necrosis, and benign radiographic changes. National experts in radiation oncology will then discuss options for management in patients who experience post-treatment toxicity after stereotactic radiosurgery.

Physician Accreditation Statement
The 黑料网 is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation
The 黑料网 designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Each session in this Webinar Series is designated for 1.0 AMA PRA Category 1 Credit™ for a total of 4.0 AMA PRA Category 1 Credits™ for the series.

Instructions to Receive Credit
In order to successfully complete the activity, participants must complete an activity evaluation and claim credit commensurate with their participation in the activity.

Contact Information
For information about the accreditation of this program, please contact the 黑料网 at info@acr.org.

Disclosure of Relevant Financial Relationships
The 黑料网 Disclosure Policy: The 黑料网 (黑料网) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by 黑料网 are required to disclose all financial relationships with any ineligible company within the past 24 months. All financial relationships reported are identified as relevant and mitigated by 黑料网 in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by 黑料网 to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by 黑料网.

The following planners and managers have no relevant financial relationships to disclose: Arya Amini, MD; Emile Gogineni DO; Theresa Rudolph; Alexis LaCount

The following faculty members have no relevant financial relationships: Arya Amini, MD and Emile Gogineni, DO

Past Webinars

Clinical Education

FLASH-RT 鈥 The Future of Radiation or A Flash in the Pan?

 

Description: This live webinar will feature presentations and an open Q&A session for participant engagement and cover the molecular mechanisms, physical and radiobiological advantages, and technological constraints of ultra-fast high dose rate photon- and particle-based FLASH radiation therapy. National experts will provide an overview of the published preclinical data and ongoing trials, highlight the potential benefits of this technique over conventional radiation, and discuss the advances needed to further enhance clinical applications of FLASH-RT. 

Moderator:

Emile Gogineni, DO
Emile Gogineni, DO

 

Speakers:

Charles Simone II, MD Constantinos Koumenis, PhD    Mohammad Rezaee, PhD, MCCPM
Charles Simone II, MD Constantinos Koumenis, PhD
  Mohammad Rezaee, PhD, MCCPM
         

Simulation Free Radiation Therapy - A Novel Technique for Patients with a Need for Speed

 

Description: This webinar will cover physics/dosimetry considerations, current clinical applications, and future directions of simulation free radiation therapy (SFRT). International experts will provide an overview of the rationale for SFRT, techniques utilized globally, and the process involved with establishing a SFRT program.

Moderator:

Emile Gogineni, DO

   

Speakers:

   

Aaron Bush, MD

Thomas Eade, MBBS

Melissa O'Neil, RT

 

Program Materials

Requirements:

  1. Title of Activity: Radiation Oncology Webinar Series
  2. Date of Activity: May 17, 2023 
  3. Educational/Learning Objectives
    1. After completing this activity, the participant should be better able to:
      1. Explain the history and current state of emerging radiation oncology treatment technologies.
      2. Identify research opportunities and clinical trials currently available related to emerging radiation oncology treatment technologies.
      3. Review active utilization of emerging radiation oncology treatment technologies domestically and abroad.
      4. Discuss future directions of emerging radiation oncology treatment technologies and the potential implications.
  4. Physician Accreditation Statement (must stand-alone)
    1. The 黑料网 is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  5. Physician Credit Designation (must stand-alone)
    1. The 黑料网 designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  6. Instructions to Receive Credit
    1. In order to successfully complete the activity, participants must complete an activity evaluation and claim credit commensurate with their participation in the activity.
  7. Contact Information
    1. For information about the accreditation of this program, please contact the 黑料网 at info@acr.org.
  8. Disclosure of Relevant Financial Relationships
    The 黑料网 Disclosure Policy: The 黑料网 (黑料网) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by 黑料网 are required to disclose all financial relationships with any ineligible company within the past 24 months. All financial relationships reported are identified as relevant and mitigated by 黑料网 in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by 黑料网 to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by 黑料网.

    The following planners and managers have no relevant financial relationships to disclose:
    Aaron Bush, MD; Carlye Armstrong, CHCP; Emile Gogineni DO; Maya Grant; Theresa Rudolph, CAPM

    The planners and managers have the following identified relevant financial relationships: 
    Arya Amini, MD - Consulting Fee: AstraZeneca; Contracted Research: Genentech, Varian, ReleXion; Speakers’ Bureau: AstraZeneca, Takeda Pharmaceutical 

    The following faculty members have no relevant financial relationships to disclose:
    Aaron Bush, MD
    Thomas Eade, MBBS
    Melissa O’Neil, RT

Radiopharmaceuticals: Established Evidence and Process of Implementation of a Theranostics Program

 

Description: This webinar will cover the radiobiological background, current clinical applications, and future directions of oncologic theranostics. National experts will provide an overview of the rationale for the use of diagnostic and therapeutic radionuclides, published translational and clinical data in addition to ongoing trials, and the process involved with establishing a theranostics program.

Moderators

  • Emile Gogineni, DO and Aaron Bush, MD

Program Materials

Requirements:

  1. Title of Activity: Radiation Oncology Webinar Series
  2. Date(s) of Activity: February 15, 2023
  3. Educational/Learning Objectives
    1. After completing this activity, the participant should be better able to:
      1. Explain the history and current state of emerging radiation oncology treatment technologies.
      2. Identify research opportunities and clinical trials currently available related to emerging radiation oncology treatment technologies.
      3. Review active utilization of emerging radiation oncology treatment technologies domestically and abroad.
      4. Discuss future directions of emerging radiation oncology treatment technologies and the potential implications.
  4. Physician Accreditation Statement (must stand-alone)
    1. The 黑料网 is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  5. Physician Credit Designation (must stand-alone)
    1. The 黑料网 designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  6. Instructions to Receive Credit
    1. In order to successfully complete the activity, participants must, complete an activity evaluation and claim credit commensurate with their participation in the activity.
  7. Contact Information
    1. For information about the accreditation of this program, please contact the 黑料网 at info@acr.org.
  8. Disclosure of Relevant Financial Relationships
    The 黑料网 Disclosure Policy: The 黑料网 (黑料网) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by 黑料网 are required to disclose all financial relationships with any ineligible company within the past 24 months. All financial relationships reported are identified as relevant and mitigated by 黑料网 in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by 黑料网 to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by 黑料网.

    The following planners and managers have no relevant financial relationships to disclose:
    Aaron Bush, MD; Carlye Armstrong, CHCP; Emile Gogineni DO; Maya Grant; Theresa Rudolph, CAPM

    The planners and managers have the following identified relevant financial relationships:
    Arya Amini, MD - Consulting Fee: AstraZeneca; Contracted Research: Genentech, Varian, ReleXion; Speakers’ Bureau: AstraZeneca, Takeda Pharmaceutical

    The following reviewers have no relevant financial relationships to disclose:
    Carlye Armstrong, CHCP

    The following faculty members have no relevant financial relationships to disclose:
    Freddy E Escorcia, MD, PhD

    The faculty members (speakers, etc.) have the following identified relevant financial relationships:
    Ephraim E. Parents, MD, PhD – Consulting fee: Blue Earth Diagnostics

Oligometastases: An Evolving Frontier in Radiation Oncology

 

Description: This webinar will cover current clinical applications and future directions of definitive management for patients with oligometastatic disease. National experts will cover oligometastatic disease related topics such as ongoing clinical trials, current disease site specific recommendations, and case based considerations.

Moderator

  • Aaron Bush MD, 黑料网 RO Webinar Lead

Speakers

  • Abhishek Solanki, MD
  • Jillian Tsai, MD
  • Puneeth Iyengar, MD, PhD

Highlights

  • Inform participants on the state of definitive management for oligometastases in radiation oncology today.
  • Explore ongoing clinical trials currently available related to oligometastatic disease management.
  • Consider future directions of radiotherapy for oligometastases and the potential implications.

Artificial Intelligence in Radiation Oncology 鈥 Rise of the Machines

 

 

 

Description: This webinar will explore themes related to current clinical applications and future directions of artificial intelligence (AI) in radiation oncology. National experts will cover AI-related topics such as enhancements in treatment planning, improved workflow efficiency, machine learning, and future job market implications. 

Moderator

  • Aaron Bush, MD, Lead 黑料网 Radiation Oncology Webinars

Highlights

  • Inform participants on the state of AI implementation in radiation oncology clinics today.
  • Explore national research opportunities currently available related to AI applications.
  • Consider future directions of AI in radiation oncology and its potential implications. 

Heavy Ion Radiotherapy: Ongoing Clinical Applications and Future Directions

 

 

Description: This webinar will explore themes related to the innovative topic of heavy ion radiotherapy (carbon, neon, silicon, etc). International experts will cover topics such as current basic research opportunities in the United States, ongoing clinical applications abroad, and future directions of heavy ion radiotherapy.

Moderator

  • Aaron Bush, MD, Lead 黑料网 Radiation Oncology Webinars

Speakers

  • Timothy Malouff, MD, PGY5 Radiation Oncology Mayo Clinic presents “Heavy Ion Radiotherapy: An Introduction”
  • Hiroshi Tsuji, MD, PHD, Director of National Institutes for Quantum Science and Technology Hospital, Chiba, Japan presents "Heavy Ion Radiotherapy: Ongoing Clinical Applications and Future Directions"

Highlights

  • Educated participants on the history and current state of heavy ion radiotherapy.
  • Explored basic research opportunities currently available within the United States.
  • Discussed active utilization of heavy ions in the clinical setting internationally.
  • Consider future directions of heavy ion therapy domestically and abroad.                                                                                                                                                                                                               

Health Policy and Economics

Declining Applicant Numbers in the Radiation Oncology Match 鈥 How Should We Respond?

 

Description: In this webinar, a diverse panel of expert radiation oncologists and a 4th year medical student focus on raising awareness on the declining applicant numbers in the radiation oncology match.

Moderator

  • Aaron Bush, MD, Lead 黑料网 Radiation Oncology Webinars

Panelist

  • Brian D. Kavanagh, MD, MPH (Professor and Chair UCHealth Radiation Oncology)
  • Alan Hartford, MD, PhD, F黑料网 (Professor of Medicine (Radiation Oncology) at MGH
  • Neha Vapiwala, MD F黑料网 FASTRO (Professor and Vice Chair of Education, Radiation Oncology UPenn)
  • Guest Panelist Erica Braschi MS4 (University of Florida of Medicine)

 Highlights

  • Inform participants on recent trends in the radiation oncology match.
  • Identify etiologies for declining radiation oncology applicant match numbers.
  • Openly discuss how to appropriately respond to decreasing applicant numbers.
  • Explore potential interventions to increase future applicant numbers.                                                          

Hosted by:

黑料网 Commission on Radiation Oncology

Radiation Oncology Alternative Payment Model

 

Description: Panel discussion with the Center for Medicare and Medicaid Innovation Center (CMMI) radiation oncology alternative payment model (RO-APM) team lead and radiation oncology economics experts.

Moderator

  • Aaron Bush, MD, Lead 黑料网 Radiation Oncology Webinars

Panelist

  • Join Luh, MD F黑料网
  • Najeeb Mohideen, MD
  • Marcie O’Reilly, CMMI

Radiation Oncology Advocacy Webinar

This webinar will focus on advocacy efforts in radiation oncology and how to leverage the resources of organized medicine groups such as the 黑料网 to advocate for the best oncologic treatments for patients.

Panelists

  • Amar Rewari, MD, MBA and Paul Wallner, DO, F黑料网, FASTRO

 

Hosted by:

The 黑料网 Commission on Radiation Oncology Education Committee

 

Radiation Oncology Job Market Concerns

In this webinar, diverse panelists discusses job market concerns in radiation oncology in the context of the COVID-19 pandemic.



Panelists

  • Anna Laucis, MD, MPhil (moderator)
  • Hina Saeed, MD (moderator)
  • Jerome M. Butler, MD (Southeast Radiation Oncology in North Carolina)
  • Vinai Gondi, MD (Radiation Oncology Consultants in Illinois)
  • Kenneth R. Olivier, MD (Mayo Clinic)
  • Carolyn Savioz, MD (University of Kansas)
  • Neha Vapiwala, MD (University of Pennsylvania)

Highlights

  • Assess the significance of job market concerns in radiation oncology
  • Recognize and understand the influence of the COVID-19 pandemic on the job market
  • Positive impact of the 黑料网 in helping with job market concerns
  • Strengths of the radiation oncology community

Professional Development

Diversity, Equity, and Inclusion in Radiation Oncology: Avenues towards Meaningful Change. Moving from Awareness to Action and Accountability

Description: This webinar will cover diversity, equity, and inclusion within the field of radiation oncology, focusing on interventions that can be employed to provide meaningful change. National experts will discuss aspects within education and training, patient care, and the workforce related to diversity, aiming to provide concrete examples of avenues to pursue in order to implement impactful changes in policy and structure. 

Moderator:

   
 
Emile Gogineni, DO
 
Curtiland Deville Jr., MD
 

Speakers:

   

Reshma Jagsi, MD, DPhil 

Jerry Jaboin, MD, PhD 

Rachel Jimenez, MD 

Program Materials

Requirements:

  1. Title of Activity: Radiation Oncology Webinar Series
  2. Date of Activity: August 16, 2023
  3. Educational/Learning Objectives
    1. After completing this activity, the participant should be better able to:
      i. Explain the history and current state of emerging radiation oncology treatment technologies.
      ii. Identify research opportunities and clinical trials currently available related to emerging radiation oncology treatment technologies.
      iii. Review active utilization of emerging radiation oncology treatment technologies domestically and abroad.
      iv. Discuss future directions of emerging radiation oncology treatment technologies and the potential implications.
       
  4. Physician Accreditation Statement 
    1. The 黑料网 is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  5. Physician Credit Designation
    1. The 黑料网 designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      Each session in this Webinar Series is designated for 1.0 AMA PRA Category 1 Credit™ for a total of 4.0 AMA PRA Category 1 Credits™ for the series.
  6. Instructions to Receive Credit
    1. In order to successfully complete the activity, participants must complete an activity evaluation and claim credit commensurate with their participation in the activity.
  7. Contact Information
    1. For information about the accreditation of this program, please contact the 黑料网 at info@acr.org.
  8. Disclosure of Relevant Financial Relationships
    The 黑料网 Disclosure Policy: The 黑料网 (黑料网) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by 黑料网 are required to disclose all financial relationships with any ineligible company within the past 24 months. All financial relationships reported are identified as relevant and mitigated by 黑料网 in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by 黑料网 to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by 黑料网.

    The following planners and managers have no relevant financial relationships to disclose:
    Aaron Bush, MD; Emile Gogineni DO; Theresa Rudolph, CAPM; Carlye Armstrong, CHCP; Maya Grant

    The following planners and managers have the following identified relevant financial relationships:
    Arya Amini, MD - Consulting Fee: AstraZeneca; Contracted Research: Genentech, Varian, ReleXion; Speakers’ Bureau: AstraZeneca, Takeda Pharmaceutical

    The following faculty members have no relevant financial relationships to disclose:
    Rachel Jimenez, MD; Jerry J. Jaboin, MD, PhD; Reshma Jagsi, MD, DPhil; Curtiland Deville, Jr., MD
     

Pandemic or Not: Empathy in Communication Is Vital

Moderator

  • Hina Saeed, MD – Medical College of Wisconsin

Panelist

  • Kavita Dharmarajan, MD, MSc – Mount Sinai Hospital, New York  
  • Joshua Jones, MD – University of Pennsylvania                                                                

 Highlights

  • Understand the importance of basic communication skills
  • Define patient-centered communication and understand its impact on the patient experience
  • Learn and apply frameworks for effective information sharing
  • Apply effective communication to patient interactions during a pandemic

Presented by:

黑料网 Commission on Radiation Oncology Education and CARROS

Radiation Oncology Diversity Equity and Inclusion Webinar

In this webinar, a diverse panel of expert 黑料网 radiation oncologists will explore themes related to diversity, equity and inclusion, associated challenges and benefits, and framework for solutions to these challenges for diversity & inclusion in the radiation oncology field.

 

Moderator

  • Moderators: Anna M. Laucis, MD, MPhil and Hina Saeed, MD

Panelist

  • Curtiland Deville, MD
  • Stephanie Terezakis, MD
  • Join Luh, MD
  • Malika Siker, MD

Hosted by:

Theresa Powell 黑料网 (黑料网) Commission on Radiation Oncology(RO) Education Committee

 Highlights

  • Educate participants about diversity and inclusion principles in radiation oncology
  • Explore the benefits of having a diverse provider workforce in radiation oncology
  • Identify the challenges associated with implementing diversity programs
  • Outline framework for potential solutions to challenges in diversity and inclusion                                                 

 

Educational Links Discussed in the webinar:

  • Great resource by Dr. Charles Thomas to support URM faculty: 

 

Radiation Oncology Leadership Perspectives

In this webinar, a diverse panel of four expert oncologists focus on leadership perspectives, mentorship, sponsorship, career advice challenges and opportunities in the radiation oncology field.



Panelists

  • Anna Laucis, MD, MPhil (moderator)
  • Albert Blumberg, MD, Past 黑料网 President
  • Camille Williams, MD, 黑料网 Commission for Women and Diversity Leader
  • Daniel Chang, MD, Editor for the GI section of the 黑料网 Journal Advisor
  • Naomi Schechter, MD, Practice Parameter lead for the 黑料网 Radiation Oncology Commission 

Highlights

  • Importance of health care organizations increasing physician engagement
  • Factors and influences of healthcare success
  • Removing the barriers for physician success in leadership roles and functions
  • Steps for driving performance excellence
Send your suggestion to the radiation oncology webinar team with a brief description of your webinar topic and how your topic is different, needed or why it matters.